Premium
Comparative Proteomics Analysis of the Proteins Associated With Laryngeal Carcinoma‐Related Gene 1
Author(s) -
Zhang Xiaopeng,
Xiao Zhiqiang,
Chen Zhuchu,
Li Cui,
Li Jianling,
Yanhui Yu,
Yang Fang,
Yang YiXuan,
Oyang Yongmei
Publication year - 2006
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/01.mlg.0000191470.71454.a1
Subject(s) - microbiology and biotechnology , cell culture , transfection , mass spectrometry , gel electrophoresis , chemistry , blot , proteomics , gene , plasmid , biology , two dimensional gel electrophoresis , genetics , biochemistry , chromatography
Objectives: A novel gene, laryngeal carcinoma‐related gene 1 (LCRG1), had the characteristics of tumor‐suppressor genes. It was cloned in our laboratory. The objective was to find and characterize the proteins related to LCRG1 and to elucidate the molecular mechanism of LCRG1. Study Design: We used the established cell lines of Hep‐2/LCRG1 (Hep‐2 cells transfected by recombinant plasmid pcDNA3.1[+]/LCRG1) and Hep‐2/pcDNA3.1(+) (Hep‐2 cells transfected by control vector pcDNA3.1[+]) as cell models. Methods: Two‐dimensional gel electrophoresis (2‐DE) technology was performed to separate the proteins of Hep‐2/LCRG1 and Hep‐2/pcDNA3.1(+) cell lines, respectively. The differential protein spots were analyzed by software analysis, subject to in‐gel digestion, and identified by Matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOF‐MS) and electrospray ionization–quadruple time‐of‐flight MS/MS (ESI‐Q‐TOF MS/MS). Then the differential expression levels of partial identified proteins were determined by Western blotting analysis and quantitative real‐time reverse transcriptase–polymerase chain reaction. Results: The results showed the attained 2‐DE patterns of the two cell lines were well‐resolved and reproducible. There were 1075 ± 43 and 1027 ± 23 protein spots observed in Hep‐2/LCRG1 and Hep‐2/pcDNA3.1(+) cell lines, respectively. The average matching rate of the two cell lines was 91%. Twenty‐six differentially expressed protein spots were identified (twenty spots for MALDI‐TOF‐MS, six spots for ESI‐Q‐TOF MS/MS). Most of the characterized proteins were characterized as the members of enzymes (phosphoglycerate mutase, manganese superoxide dismutase, and so on), transcription proteins (rho gdp dissociation inhibitor), and so on. Those identified proteins might contribute to the tumor‐suppressive function of LCRG1. The differential expression levels of the partial proteins were confirmed by real‐time polymerase chain reaction and Western blotting. Conclusions: We tentatively proposed those differentially expressed proteins were involved in the tumor‐suppressive process related to LCRG1. These data will be helpful to elucidate the molecular mechanism of LCRG1.